Introduction: The Hidden Lever in MedTech Product Development
Every MedTech spin-out starts with energy: fresh thinking, clinical purpose, and an ambition to make a real-world difference. It’s what makes early-stage innovation so rewarding.
But there’s one conversation we aim to have early with every founder we meet:
Your regulatory strategy will define your development pathway. And your budget.
The Cost of Getting It Wrong
Regulation isn’t just an endpoint. It’s a controlling influence on:
- What you develop
- How you design and test it
- How fast you can move
- How much you’ll spend
A poor regulatory strategy doesn’t just delay your CE mark or FDA 510(k). It can multiply your development costs tenfold.
We’ve seen:
- Brilliant teams burning through runway on non-viable development paths
- Premature investment in prototyping before classification is confirmed
- Entire product concepts reworked due to misjudged regulatory assumptions
All of it avoidable.
You Can’t Outsource Accountability
Yes, regulatory consultants are valuable. They provide clarity, gap analysis, and documentation support.
But they do not own your compliance.
The spin-out, not the consultant, is responsible for:
- The Quality Management System (e.g., ISO 13485)
- Risk management and design controls (e.g., ISO 14971)
- Verification and validation planning
- Post-market surveillance and ongoing compliance
Responsibility can be supported. But it cannot be delegated.
Strategy Before Spending
Founders often ask us when to engage a product design partner.
Our answer:
- Engage once you have a clear sense of intended use and classification
- Involve your design team early in risk analysis and usability planning
- Map the regulatory route before mapping the prototype
This changes everything: what you build, how you test it, and when you raise capital.
Maddison’s Role in Regulatory-Aware Design
We don’t file your technical dossier. But we do:
- Design for compliance from day one
- Support risk management documentation
- Deliver usability validation aligned to ISO 62366 and FDA expectations
- Collaborate closely with your regulatory advisor to align product features with approval strategy
Because we know the fastest path to market is the one that doesn’t go backwards.
Final Word: Own the Responsibility Early
You can’t fix regulatory missteps with more budget. You fix them with better decisions upstream.
If you get your regulatory strategy right early, you protect your cash, your timeline, and your investor trust.
Need help designing with regulation in mind? Let’s talk.
Rob Butterfield, Managing Director
rob.butterfield@maddison.co.uk